HOUSTON AREA MULTIPLE MYELOMA SUPPORT GROUP
HOMEPAGE
Monthly Meetings:
3rd Saturday monthly @ American Cancer
Society (ACS)
6301
2004 Meeting Schedule:
January
17
February 21
March 20
April 17
May 15
June 19
July 17
August 21
September 18
October 16
November 20
December 18
The
Support Group Leader:
Monthly Newsletters:
June 2004 MM Newsletter (click here)
May 2004 MM Newsletter (click here)
April 2004 MM Newsletter (click here)
March 2004 MM Newsletter (click here)
February 2004 MM Newsletter (click here)
January 2004
MM Newsletter (click here)
2003 Newsletters (click here)
Newest news links and tips:
04/24/2004 Recent;ly published Dental Journal Article (2204 American Association of Oral and Maxillofacial Surgeons) linking Bisphosphonates (Aredia and Zometa) to bone loss, especially in the upper jaw, resulting in tooth loss. The article is entitled:
"Osteonecrosis of the Jaws Associated With the Use of Bisphosphonates: A review of 63 Cases" (click here)
The study was done by the Long Island Jewish Medical Center (New York) and The University of Maryland.
· Presentation slides (52 in Adobe Acrobat format) from the
Dr. Aggarwal,
lead researcher at M.D. Anderson Cancer Center, shares information on a natural
curry spice research project: “How TUMERIC-CURCUMIN
May Help Suppress & Destroy the Blood Cancer MM”.
(You may have to minimize to see slides
on background screen.)
·
VELCADE is approved by
FDA for Relapsed and Refractory Myeloma (
·
The
American Cancer Society (ACS) provides their building in
·
Have
your found http://www.acor.org/ (Association
of Cancer Online resources)? This webisite provides
interactive internet chats. All cancer
types are listed there, but you can sign up for just the specific cancer you
are interested in receiving current e-mails on.
I chose “Mailing Lists”, then the letter M to sign up for Multiple
Myeloma e-mails only. Paged down to
Multiple Myeloma (1191 subscribers) and “clicked” to add myself, meaning I can
received from others on the list and am free to respond (to one or all on list)
or ignore (delete) if they do not interest me.
People often call the support group asking for a contact who has
experienced various drug treatments, responses, shingles, neuropathy, latest
treatments available and where (different facilities offer different things),
insurance coverage (which are different for different carriers), VA benefits,
SSA benefits, national and international doctors and facilities, and patient
experiences. Support groups are usually
small, and some of the info is out-dated (STC 3 years ago and differing protocols),
and then patient MM type and important makers for that type make patient
comparisons sot always accurate (apples vs. oranges). ACOR helps to access specific and more
current information quickly (and has an search archive so you can pull up
messages for only VELCADE discussions, and you can talk to 25 VELCADE stories
instead of just 2 people in your support group who are aware of it or have had
an experience with it.
·
Dana-Farber’s
neuropathy meds regimen posted on web
See the Clinical Trials Monitor to see what’s
available: CTM
Multiple Myeloma Patient
Support/Research/Education/Advocacy:
IMF International
Myeloma Foundation
MMRF Multiple
Myeloma Research Foundation
LLS Leukemia
& Lymphoma Society (includes Myeloma)
CanCare (Cancer Care) Cancer Support Network
ACS American
Cancer Society
Websites for Multiple Myeloma facilities in the US
(for
a link to these websites and others, see
Cancer Index – Cancer Centers
& Institutes):
Dana-Farber Cancer Institute (
H. Lee Moffitt Cancer Center & Research Institute
(
Mayo Clinic (
University of
University of
For an index of links to all sorts of additional MM
information, click here.
To help from home (advocacy) with extremely little
effort on your part, click here.
Please ADD me to the distribution list:
(signify e-mail, regular
mail, or both and provide addresses) click
here.
Please REMOVE me from the distribution list:
(signify
e-mail, regular mail, or both and provide name)
click
here.
FEEDBACK/SUGGESTIONS for Webpage Improvement: click
here.
Webmaster: Joan Butzke (281-437-6653) or
bbutzke@houston.rr.com